InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Moran Michael Shawn, Executive. Director active across 1 company, notably Eagle Pharmaceuticals, INC.. Aggregated, 5 filings have been published. Activity tracked since 5 January 2022. The latest transaction was filed on 28 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Moran Michael Shawn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
10,400 shares0Common StockSEC:0001209191-22-015024:0
742 shares@ US$45.030.90% mcap13.4% of flowCommon StockSEC:0001209191-22-007222:0
210 shares@ US$45.940.26% mcap3.9% of flowCommon StockSEC:0001209191-22-006051:0
90 shares@ US$50.630.12% mcap1.8% of flowCommon StockSEC:0001209191-22-002886:0
1,511 shares@ US$50.692.06% mcap30.8% of flowCommon StockSEC:0001209191-22-002419:0
5 of 5 declarations
About Moran Michael Shawn
Michael Shawn Moran is EVP and Chief Commercial Officer at Eagle Pharmaceuticals, Inc. In this role, he is responsible for the company's commercial strategy and business development. His experience in the pharmaceutical sector enables him to lead initiatives aimed at strengthening the company's market position.
